148 related articles for article (PubMed ID: 34160336)
1. A clinical observational study on the efficacy of subcutaneous etonogestrel implants for adenomyosis in 20 patients.
Nie L; Zou H; Ma X; Cheng L; Jiao J; Wang F; Liang W; Zhang P
Gynecol Endocrinol; 2021 Aug; 37(8):735-739. PubMed ID: 34160336
[No Abstract] [Full Text] [Related]
2. Treatment of Adenomyosis with Subcutaneous Etonogestrel Implants: A Clinical Observational Study in 17 Patients.
Wu J; Huang Y; Chen L; Hu J; Zou Y
Med Sci Monit; 2018 Sep; 24():6085-6092. PubMed ID: 30171680
[TBL] [Abstract][Full Text] [Related]
3. Effects of Etonogestrel implants on pelvic pain and menstrual flow in women suffering from adenomyosis or endometriosis: Results from a prospective, observational study.
Niu X; Luo Q; Wang C; Zhu L; Huang L
Medicine (Baltimore); 2021 Feb; 100(6):e24597. PubMed ID: 33578561
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of etonogestrel subcutaneous implants versus the levonorgestrel-releasing intrauterine system in the conservative treatment of adenomyosis.
Wei A; Tang X; Yang W; Zhou J; Zhu W; Pan S
Open Med (Wars); 2024; 19(1):20240914. PubMed ID: 38584829
[TBL] [Abstract][Full Text] [Related]
5. Subcutaneous etonogestrel implant combined with endometrial ablation for the treatment of adenomyosis: two case reports.
Nie LK; Zou HL; Cheng L; Zhang PH
J Obstet Gynaecol Res; 2022 Jan; 48(1):262-265. PubMed ID: 34713941
[TBL] [Abstract][Full Text] [Related]
6. Vaginal bromocriptine improves pain, menstrual bleeding and quality of life in women with adenomyosis: A pilot study.
Andersson JK; Khan Z; Weaver AL; Vaughan LE; Gemzell-Danielsson K; Stewart EA
Acta Obstet Gynecol Scand; 2019 Oct; 98(10):1341-1350. PubMed ID: 31025313
[TBL] [Abstract][Full Text] [Related]
7. The treatment with Levonorgestrel Releasing Intrauterine System (LNG-IUS) in patients affected by menometrorrhagia, dysmenorrhea and adenomimyois: clinical and ultrasonographic reports.
Costanzi F; De Marco MP; Colombrino C; Ciancia M; Torcia F; Ruscito I; Bellati F; Frega A; Cozza G; Caserta D
Eur Rev Med Pharmacol Sci; 2021 May; 25(9):3432-3439. PubMed ID: 34002816
[TBL] [Abstract][Full Text] [Related]
8. Transvaginal sonographic features of diffuse adenomyosis in 18-30-year-old nulligravid women without endometriosis: association with symptoms.
Pinzauti S; Lazzeri L; Tosti C; Centini G; Orlandini C; Luisi S; Zupi E; Exacoustos C; Petraglia F
Ultrasound Obstet Gynecol; 2015 Dec; 46(6):730-6. PubMed ID: 25728241
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy of myometrial and endometrial microwave ablation in the treatment of patients with adenomyosis who had anemia.
Li Z; Li X; Lin M; Qiu S; Wang L; Lai L; Luo X; Mo Z; Dong G; Lyu G; Li S
Int J Hyperthermia; 2022; 39(1):1335-1343. PubMed ID: 36257919
[TBL] [Abstract][Full Text] [Related]
10. Menorrhagia and Uterine Volume Associated with Lower Urinary Tract Symptoms in Patients with Adenomyosis.
Li T; Xu XX; Dai Y; Zhang JJ; Lang JH; Leng JH
Chin Med J (Engl); 2017 Jul; 130(13):1552-1556. PubMed ID: 28639570
[TBL] [Abstract][Full Text] [Related]
11. Clinical experiences of the levonorgestrel-releasing intrauterine system in patients with large symptomatic adenomyosis.
Park DS; Kim ML; Song T; Yun BS; Kim MK; Jun HS; Seong SJ
Taiwan J Obstet Gynecol; 2015 Aug; 54(4):412-5. PubMed ID: 26384061
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic Uterine Artery Occlusion Combined with Uterine-sparing Pelvic Plexus Block and Partial Adenomyomectomy for Adenomyosis: A Video Case Report.
Chen D; Ai G; Yang W; Liu J; Luo N; Guo J; Cheng Z
J Minim Invasive Gynecol; 2021 Oct; 28(10):1681-1684. PubMed ID: 34051355
[TBL] [Abstract][Full Text] [Related]
13. Treatment of symptomatic adenomyosis with the levonorgestrel-releasing intrauterine system.
Li L; Leng J; Jia S; Lang J
Int J Gynaecol Obstet; 2019 Sep; 146(3):357-363. PubMed ID: 31194884
[TBL] [Abstract][Full Text] [Related]
14. Effect of Mifepristone vs Placebo for Treatment of Adenomyosis With Pain Symptoms: A Randomized Clinical Trial.
Che X; Wang J; Sun W; He J; Wang Q; Zhu D; Zhu W; Zhang J; Dong J; Xu J; Zheng F; Zhou J; Zhao W; Lin Q; Ye L; Zhao X; Xu Z; Chen Y; Wang J; Wu W; Zhai L; Zhou Y; Zheng J; Zhang X
JAMA Netw Open; 2023 Jun; 6(6):e2317860. PubMed ID: 37307001
[TBL] [Abstract][Full Text] [Related]
15. Low-dose letrozole - an effective option for women with symptomatic adenomyosis awaiting IVF: a pilot randomized controlled trial.
Sharma S; RoyChoudhury S; Bhattacharya MP; Hazra S; Majhi AK; Oswal KC; Chattopadhyay R
Reprod Biomed Online; 2023 Jul; 47(1):84-93. PubMed ID: 37149412
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy and feasibility of levonorgestrel-releasing intrauterine device use in patients with adenomyosis.
Song SY; Lee SY; Kim HY; Park DB; Kim DE; Lee KH; Lee S; Yang JB; Yoo HJ
Medicine (Baltimore); 2020 May; 99(22):e20421. PubMed ID: 32481439
[TBL] [Abstract][Full Text] [Related]
17. Combination of microwave endometrial ablation and postoperative dienogest administration is effective for treating symptomatic adenomyosis.
Ota K; Takahashi T; Shiraishi S; Mizunuma H
J Obstet Gynaecol Res; 2018 Sep; 44(9):1787-1792. PubMed ID: 29998482
[TBL] [Abstract][Full Text] [Related]
18. Early removal of etonogestrel subcutaneous contraceptive implant at a community health centre in Pretoria.
Moeti DMP; Govender I; Bongongo T
S Afr Fam Pract (2004); 2022 Jul; 64(1):e1-e6. PubMed ID: 35924618
[TBL] [Abstract][Full Text] [Related]
19. [A prospective study on the effects of levonorgestrel-releasing intrauterine system for adenomyosis with menorrhagia].
Li L; Leng JH; Shi JH; Zhang JJ; Jia SZ; Li XY; Dai Y; Zhang JR; Li T; Xu XX; Liu ZZ; You SS; Chang XY; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2016 Jun; 51(6):424-30. PubMed ID: 27356477
[TBL] [Abstract][Full Text] [Related]
20. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system.
Fong YF; Singh K
Contraception; 1999 Sep; 60(3):173-5. PubMed ID: 10640162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
